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Abstract
Objectives With increasing experience, endovascular aortic
aneurysm repair (EVAR) has been extended to patients with
less suitable aorto-iliac anatomy in an attempt to reduce
peri-operative mortality. However, more complex EVAR
procedures may take longer and can result in higher rates of
complications, additional interventional procedures and
more frequent radiological imaging, which may offset some
of the benefit. This study determined the radiation burden
for standard EVAR, as determined by the EVAR-1 trial
criteria, and more complex EVAR.
Methods A total of 123 elective patients aged >60, with
aneurysms>5.5cmwhoreceivedabifurcatedstent-graftwere
allocated into a group based on whether or not they fulfilled
strict EVAR-1 trial criteria. The mean radiation dose was
calculated for each group, together with the additional
radiation burden from routine pre- and post-EVAR CT
examinations and pre-EVAR iliac artery embolisation.
Results Patients not meeting the EVAR-1 trial criteria had
significantly longer fluoroscopic screening times and higher
radiation doses. The radiation burden in all patients was
higher following exposure from routine CT examinations
and following pre-EVAR iliac artery embolisation.
Conclusion Whilst the radiation from standard EVAR is
acceptable, more complicated and challenging EVARs,
accompanied with additional radiological investigations





In the early 1990s, endovascular aortic aneurysm repair
(EVAR) was introduced as an alternative to open repair for
the treatment of aortic aneurysms. To assess the effectiveness
oftreatingpatientswithEVARcomparedwithopenaneurysm
repair, two large randomized multicentre trials (EVAR-1 [1]
and DREAM [2] Trials) were undertaken between 1999 and
2003. In the EVAR-1 Trial, patients were selected based on
their fitness to undergo surgery and specific criteria relating
to aortic aneurysm morphology considered favourable for
EVAR. The results were published in 2004 and revealed that
patients who underwent EVAR, but who were fit enough for
open aneurysm repair, had fewer post-procedural complica-
tions, a reduced hospital stay and a 3% reduction in 30-day
mortality (1.7% vs 4.7%) [1]. Furthermore, at 4 years of
follow-up, the EVAR-1 Trial also demonstrated a persistent
reduction in aneurysm-related mortality in EVAR patients
compared with those who received open repair (4% vs 7%)
[3].
Recently, there has been increasing concern regarding the
radiation risks to both the patient [4] and operator [5]f o r
fluoroscopically based interventional procedures. Indeed,
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.dose area product (DAP) values have been reported as high
as 125,338 and 459 Gy.cm
2 for cardiac-, neuro- and
intravascular abdominal-interventional procedures, respec-
tively [6, 7]. However, there is a certain inconsistency within
the literature for the average radiation dose a patient receives
from an EVAR procedure, with values ranging from 43 to
150 Gy.cm
2 [8–10]. This has resulted in uncertainty amongst
interventional radiologists as to the potential long-term
effects which these doses of radiation may be having on
patients. This is further compounded by the number of
computerised tomography (CT) examinations undertaken
both before and after EVAR; each of which exposes the
patient to a further dose of ionizing radiation. Indeed, a
recent study estimated the average EVAR patient undergoes
five CT examinations with intravenous contrast medium
within their first 2 years [11]. In addition, clinicians are also
undertaking increasingly complex EVAR procedures in
patients with less favourable aortic and iliac anatomy, which
require longer fluoroscopic screening times. Many of these
procedures also require additional radiological interventions
such as pre-EVAR occlusion of internal iliac arteries and
post-operative embolisation/coiling for type II endoleaks
associated with aneurysm sac expansion. These more
complex EVAR procedures are also more likely to develop
stent related complications, such as proximal type I
endoleaks and graft limb dislocations, which again will
require further evaluation with CT and/or angiograms
followed by correction with re-EVAR procedures. Further-
more, there is also a trend to now advocate EVAR in younger
patients who have both a low risk for an open repair [12]a n d
a greater lifetime risk of developing cancer following
radiation exposure.
One explanation for the inconsistency in the radiation
dose received by patients undergoing EVAR could be the
range of complexity of the procedure within the groups
being analysed. Hence, the present study retrospectively
divided patients who received a bifurcated aortic stent graft
into two groups, depending on the complexity of the EVAR
procedure as determined by the anatomical criteria for the
EVAR-1 Trial, with those patients meeting the criteria
having aneurysms deemed to be less complicated. We
hypothesize patients who have more complex aortic
anatomy will have more complicated procedures with




Our unit has been performing EVAR since 2002 and was a
participant in the EVAR-1 Trial. A consultant interventional
radiologist and consultant vascular surgeon jointly per-
formed each EVAR procedure. In the present study,
radiation dose data was retrospectively collected for all
patients who underwent elective EVAR in our tertiary
referral vascular unit. Of the 203 patients in our database,
only 123 were selected for the analysis in the present study
since these patients were suitable candidates for either
elective open or endovascular repair, aged over 60, had an
abdominal aortic aneurysm diameter >5.5 cm and under-
went an elective EVAR with a bifurcated aortic stent. In
addition, radiation doses were collected for all patients who
underwent pre-EVAR iliac artery embolisation.
Patient subgroups
Each patient had their pre-procedural CT examination
re-reviewed by a consultant vascular radiologist, who
allocated them to a group based on whether or not they
had an aorta which fulfilled all the criteria required for
them to be entered into the EVAR-1 Trial. The inclusion
criteria included all of the following: a neck length >15 mm,
neck outer diameter <32 mm, angulation in any plane <60
o,
flare <4 mm in 1 cm, distal aorta diameter >20 mm, common
iliac artery diameter <21 mm, external iliac artery >6 mm
and a subjective impression of non-tortuous iliac arteries.
Data collection
All data was collected retrospectively as part of a medical
audit and hence ethical approval was not required. For each
patient, their age, gender, fluoroscopic screening time and
the dose of radiation received during the EVAR procedure
was collected from information electronically stored on our
picture archiving and communications system (PACS). All
patients received one CT examination pre-EVAR followed
by two surveillance CT examinations at 6 weeks and
12 months post-EVAR (as per the EVAR-1 Trial protocol).
The initial planning CT was used to determine the anatomy
of the patient’s aorta in order to correctly size the aortic
stent and determine the optimum landing zone, whilst the
surveillance CT examinations were to check for any
complications following stent placement. The average
radiation dose received from a CT aorta examination was
calculated from the parameters set in the CT protocol.
Radiation measurements
All EVAR procedures were performed in an operating theatre
using continuous fluoroscopy with a mobile digital C-arm
X-ray machine (Siemens Siremobile Compact L, Siemens
UK, Surrey, UK), with image intensifier sizes of 17 and
23 cm and a filtration of 3 mm aluminium. Imaging was
posterior-anterior with the X-ray tube (Maquet Alphamaxx,
700 Insights Imaging (2011) 2:699–704Maquet, Rustatt, Germany) placed below the operating
table. Radiation doses were measured in terms of Dose
Area Product (DAP; Gy.cm
2), by a built-in ionisation
chamber, calibrated by an independent DAP-meter (Vacu-
DAP 2000, VacuTec Meβtechnik, Dresden, Germany) and
regularly serviced every 6 months by the manufacturer. The
reproducibility of DAP readings was approximately ±1.5%.
Pre-EVAR iliac artery embolisation procedures were per-
formed in a dedicated interventional fluoroscopy suite.
Planning and surveillance CT examinations were per-
formed using one of two CT systems (Siemens Sensation 16
and SiemensSensation 64, Siemens Medical,Bracknell,UK),
using the same standardised aorta protocol, with 5-mm
unenhanced slices and 1-mm slices following intravenous
contrast medium (all at 120 kV with modulation of the tube
current with respect to patient size: approx 120–160 mA).
Radiation doses were measured in terms of dose length
product (DLP; mGy.cm) and were automatically recorded at
the time of CT data acquisition based on the CT parameters
and independently verified using a 10 cm long pencil
ionisation chamber (Radcal 20X6-3CT, Radcal corporation,
Monrovia, CA, USA).
From the DAP data, the total body effective dose (ED),
measured in milli-Sieverts (mSv), for the average size
patient was calculated using a verified Monte Carlo
computer program (PCXMC 1.5; STUK; Radiation and
Nuclear Safety Authority, Helsinki, Finland). The PCXMC
1.5 based its calculations for EVAR on a focus to skin
distance of 30 cm, tube voltage of 90 kVp and beam area of
254 cm
2. From the DLP data, the ED in mSv was
calculated based on methods described by Huda and
colleagues (conversion factor=0.0175) [13]. Both the
DAP and DLP were converted to mSv in order for the
cumulative dose of radiation to be calculated for analysis.
Data and statistical analysis
Values for all variables were expressed as the mean±SEM.
All measured variables were first analysed for normality of
distribution and then assessed using an unpaired t-test
comparing the effect of aortic anatomy complexity as
determined by the EVAR-1 trial criteria. For all compar-
isons, statistical significance was accepted when P<0.05.
Results
Patient data
From the 123 patients aged over 60 who underwent elective
EVAR with a bifurcated stent, 61 patients had aortic
anatomy which would have allowed them to be entered
into the EVAR-1 Trial, whilst 62 patients failed to meet one
or more of the entrance criteria (Table 1). Between the two
groups, patients were of a similar age [74.0±0.8 (61-68) vs
74.8±0.4 (64-68) years] and had a similar AAA diameter
[6.4±0.1 (5.5-8.7) vs 6.2±0.1 (5.5-8.6) cm]. In both groups
there was a similar overall male gender bias (male:female
ratio was 58:3 vs 57:5).
Fluoroscopic screening time and radiation burden
from EVAR
Patients who failed to meet the EVAR-1 trial criteria had a
significantly longer mean fluoroscopic screening time [28.6±
1.8 (10.1-78.0) vs 22.4±1.3 (8.4-56.7) min] associated with a
significantly higher mean radiation dose [DAP: 134.6±9.6
(34.8-459.7)vs90.7±5.5(11.0-190.8)Gy.cm
2; ED: 25.3±1.8
(6.5-86.5) vs 17.1±1.0 (2.1-35.9) mSv; Fig. 1].
Radiation burden from additional radiological examinations
Ofthe123patientsselectedforanalysis,11patientsunderwent
pre-EVAR iliac artery embolisation with an average radiation
dose (DAP) of 137.2±24.3 Gy.cm
2 and an ED of 25.8±
4.6 mSv. Of these, four patients met the criteria whilst seven
patients did not meet the criteria for the EVAR-1 trial.
Using our CT aorta protocol, the radiation dose (DLP)
from our 16-slice CTsystem was 696 mGy.cm and from our
64-slice CT system was 1137 mGy.cm, giving an average
radiation dose for a CT aorta in our institution at
916.5 mGy.cm (DLP) or 16.0 mSv (ED).
Hence, if a patient failed to meet the EVAR-1 trial
criteria, they could potentially receive as much 99.1 mSv
of radiation within their first year as a result of routine CT
examinations (1×pre-EVAR and 2×post-EVAR), the
EVAR procedure itself and from a pre-EVAR iliac artery
embolisation (Table 2).
Discussion
The EVAR-1 trial demonstrated a significant reduction in
30-day post-operative morbidity and mortality in patients
undergoing EVAR compared with open aneurysm repair [1,
3]. However, this trial only selected patients based on
Table 1 Patient data
Patients who fit the
EVAR-1 trial criteria
Patients who do not fit
the EVAR-1 trial criteria
Number (male:
female ratio)
61 (58:3) 62 (57:5)
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Nevertheless, over the past few years these results have been
used to justify performing more complicated EVAR proce-
dures in patients with more challenging aortic anatomy;
however, this has not been taken into account when previous
studies have determined the average dose of radiation from an
EVAR procedure [8–10]. Furthermore, clinicians are becom-
ing increasingly concerned as to the risks that patients may
encounter based on the radiation dose from EVAR and its
associated pre- and post- procedural investigations. Hence,
the present study was undertaken to address these questions.
Our results show there is indeed a difference in the
radiation dose depending on the complexity of the EVAR
procedure. Patients who failed to meet the EVAR-1 trial
criteria had EVAR procedures with longer fluoroscopic
screening times associated with higher radiation doses.
However, the radiation dose from an EVAR procedure
alone, even in complicated cases, is not as high even when
compared with other interventional procedures [6, 7].
Hence, taken on their own the radiation risks from EVAR
are not high enough to affect the benefit of the reduced
morbidity and mortality offered by EVAR compared with
open aneurysm repair.
Of more concern is the additional increase in the
radiation burden when the first year CT examinations are
taken into consideration. As part of the EVAR-1 trial
protocol, every patient also received one CT examination
at 2 months pre-EVAR, to plan the procedure based on the
anatomy of their aorta, and two surveillance CT examina-
tions at 6 weeks and 12 months post-EVAR, to determine
any complications following aortic stent placement. Based
on our department’s CT protocols, the mean radiation
received from a CT aorta examination was 916.5 mGy.cm.
Hence, if a patient receives three CT examinations within
the first year, this amounts to 2,749.5 mGy.cm. When
converted to an effective dose, this works out as 48 mSv of
radiation, which is a considerable dose, especially with
respect to the average yearly background dose of only
2.4 mSv. In addition, if a patient also requires a pre-EVAR
iliac artery embolisation, then the mean radiation dose
received from this intervention was 25.8 mSv. Surprisingly,
this intervention delivered a greater dose of radiation to the
patient than an EVAR procedure itself, probably due to the
repeated fluoroscopic sequences often with oblique imag-
ing, which need to be undertaken to complete the
embolisation procedure. If this dose is also taken into
account, then the radiation burden to patients can be fairly
considerable within the first year. Although many patients
who undergo open aneurysm repair will also require at least
a pre-operative CT for planning and possibly even an early
post-operative CT for evaluation of potential intra-
abdominal complications, EVAR patients will in reality
require yearly CT examinations for lifelong surveillance of
their aortic stents, further exposing them to radiation doses
which will increase their lifetime risk of developing a
radiation-induced cancer.
In addition, up to 41% of EVAR patients have been
shown to develop post-procedural complications, with 20%
subsequently requiring fluoroscopically based radiological
re-intervention [1]. These percentages will also most likely
increase for patients who failed to meet the EVAR-1 trial
criteria, as their procedures will inevitably be more






































































Fig. 1 The fluoroscopic screening time, DAP and ED for EVAR
procedures. Bars represent the mean±SEM for the fluoroscopic
screening time (min), dose area product (DAP; Gy.cm2) and effective
dose (ED; mSv). White barpatients who fit the EVAR-1 trial criteria;
black barpatients who do not fit the EVAR-1 trial criteria. Significant
differences: *P<0.05 (unpaired t-test)
Table 2 The average radiation burden for EVAR procedures, CT aorta examinations and Iliac artery embolisation. Values are the mean doses for
each examination
Patients who fit the EVAR-1 trial criteria Patients who do not fit the EVAR-1 trial criteria
DAP (Gy.cm
2) DLP (mGy.cm) ED (mSv) DAP (Gy.cm
2) DLP (mGy.cm) ED (mSv)
EVAR procedure alone 90.7 17.1 134.6 25.3
CT aorta 916.5 16.0 916.5 16.0
Iliac artery embolization (IAE) 137.2 25.8 137.2 25.8
EVAR procedure + 3×CT aorta 65.1 73.3
EVAR procedure + 3×CT aorta + IAE 90.9 99.1
702 Insights Imaging (2011) 2:699–704may start to approach values which may justifiably raise the
concern regarding the benefits of EVAR, especially in
patients who (1) are younger, (2) require significantly
longer procedures, such as those involving fenestrated or
branched grafts (both of which were not included in the
analyses of the present paper), or (3) require a second or
even third EVAR to correct a persistent endoleak or
technical problem such as limb dislocation or graft
migration.
As the radiation from repetitive CT examinations con-
tributes to a significant proportion of the radiation burden in
patients undergoing EVAR, other imaging investigations
which do not use ionising radiation should be considered
for routine surveillance of aortic grafts, monitoring aneu-
rysm size and detecting endoleaks in order to reduce the
radiation burden to patients. These include colour Doppler
ultrasound (CDUS), contrast-enhanced ultrasound (CEUS)
and magnetic resonance angiography (MRA) [14–16].
Recently, Cantisani et al. [15] have shown that the accuracy
of CEUS in detecting endoleaks is higher than CDUS and
similar to CT and MRA. Furthermore, CEUS was noted to
be a feasible tool in the long-term surveillance after EVAR
and may better classify enoleaks missed by other imaging
modalities. MRA with the blood-pool contrast agents has
also been shown to have a higher diagnostic accuracy in the
detection of endoleaks compared with CT [16, 17].
Although MRA can suffer from susceptibility artifact from
metallic objects, most endografts now use metallic endo-
skeletons or exoskeletons that are not made from stainless
steel and hence do not interfere with diagnostic images
produced by MRA. With the knowledge of the high
radiation penalty incurred by CT in the follow-up of EVAR
patients, the current clinical practice in most departments,
including our own, is to now use non-ionising radiation
based imaging modalities, reserving the use of CT for
complicated cases.
It is difficult to draw any firm conclusions regarding
the actual risk from the radiation given to patients
during EVAR or any other interventional procedure that
uses fluoroscopic guidance. Several studies have attemp-
ted to assign cancer-related risks to interventional
procedures using the BEIR VII report [18]. The BEIR
VII report is based primarily on epidemiologic studies of
survivors of the atomic bombs using organ doses and
estimates the risk of developing cancer per unit of
radiation exposure based on populations exposed to
elevated levels of radiation [19]. Using data from the
BEIR VII report assumes a linear dose-response relation-
ship to the lower dose rate of exposure in medical
procedures. Hence, these risks are more appropriately
applied to patients who are uniformly irradiated, which is
not the case for fluoroscopic and CT examinations where
specific areas of interest are only exposed to a radiation
field. Indeed, models that use individual organ doses have
been shown to generate considerably higher radiation-
induced cancer risks. Furthermore, it would be difficult to
apply our data to such models as the dynamic nature of the
fluoroscopic examination during EVAR means that we
would be unable to assign any single organ with an
accurate dose based on the total radiation dose recorded
for the entire procedure. It is also important to appreciate
that there may be some bias from radiation absorbed by
the table, padding and variations of the tube angle and
patient size. In addition, as the majority of the patients
undergoing EVAR are elderly and often with multiple co-
morbidities, their lifetime risk of developing cancer
secondary to radiation exposure is likely to be sufficiently
low as to allow them to benefit from EVAR when
compared with the higher complication risks associated
with complicated open surgery and general anaesthesia.
In summary, uncomplicated EVAR procedures have
lower fluoroscopic screening times and deliver acceptable
doses of radiation to patients, supporting their use over
open aneurysm repair in appropriate patients. The radiation
burden significantly increases in patients who require pre-
EVAR iliac artery embolisation and when routine surveil-
lance CT examinations are taken into consideration.
Undertaking EVAR in younger patients should be viewed
with caution as these patients have a greater lifetime risk of
developing a radiation-induced cancer. Furthermore, as
repetitive CT examinations have been shown to cumula-
tively deliver high doses of radiation to patients, this
highlights the importance of following-up patients with
non-ionising radiation techniques whenever possible. More
complicated EVAR procedures in patients with less favor-
able aortic anatomy must be planned with caution, as they
will deliver larger doses of radiation. Furthermore, these
procedures are often associated with additional re-
intervention and require more frequent follow-up CT
examinations, ultimately increasing a patient’s potential
radiation-induced cancer risk. The results of the present
study highlight the issues of radiation dose associated with
EVAR procedures and related interventions, thereby allow-
ing clinicians to provide patients with the appropriate
information and counseling regarding potential levels of
exposure. In addition, these findings will help clinicians to
provide better informed consent, especially for those
patients requiring more complicated EVAR procedures.
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